Rancangan Pengembangan Aplikasi Dokumentasi Clinical Pathway Berbasis Web

Latar Belakang dan Tujuan: Stroke bukan hanya menyebabkan beban dalam dunia kesehatan akan tetapi juga membebani baik dari segi ekonomi suatu negara, dan juga secara psikologis, terutama pada keluarga dengan pasien yang mengalami kecacatan total. Biaya langsung maupun tidak langsung dari perawatan stroke diperkirakan mencapai lebih dari 65 miliar US dollar, sehingga stroke dapat digolongkan sebagai penyakit termahal setara dengan penyakit kronis diabetes dan gangguan depresi. Adanya variasi dalam pelayanan kesehatan diperkirakan membawa dampak terhadap biaya yang tidak tetap dan bahkan berlebihan. Panduan tertulis berupa Clinical Pathway (CP) diharapkan mampu mengurangi variasi biaya ini, dengan tetap mempertahankan kualitas yang baik. Metoda Penelitian: Penelitian ini merupakan penelitian observasional inferensial, dengan metoda Retrospektif Kohort. Data yang diambil adalah data sekunder di RS Bethesda Yogyakarta, berupa database komputer. Sampel yang diambil berjumlah 130 orang, baik pada kelompok kontrol (Perawatan tanpa CP), maupun pada kelompok observasi (Perawatan dengan CP). Hasil: Terdapat perbedaan signifikan terhadap biaya perawatan stroke iskemik akut setelah penerapan CP (p=0,004), dimana rerata biaya perawatan pada kelompok dengan CP sebesar Rp 8.212.656,02 dan pada kelompok tanpa CP sebesar Rp 10.659.617,72 (setelah penyesuaian dengan tingkat inflasi dari BPSI sebesar 19,08%) dengan beda rerata sebesar Rp 2.446.961,70. Kesimpulan: Clinical Pathway mampu memberikan penurunan biaya perawatan terhadap perawatan stroke iskemik akut di RS. Bethesda Yogyakarta.

Download Full-text

Using Technology to Identify Risk and Meet Demands: An Innovative Clinical Pathway

Iproceedings ◽

10.2196/iproc.6043 ◽

2016 ◽

Vol 2 (1) ◽

pp. e39

Author(s):

Sally Bradford ◽

Debra Rickwood

Keyword(s):

Clinical Pathway

Download Full-text

#611 Utilization of a clinical pathway to facilitate management of sickle cell disease-related vasoocclusive events in children

Journal of Pediatric Hematology/Oncology ◽

10.1097/00043426-199807000-00048 ◽

1998 ◽

Vol 20 (4) ◽

pp. 376

Author(s):

W. C. Owen ◽

J. P. Pestian ◽

S. Hughes ◽

A. D. Wenger ◽

E. Vasser ◽

...

Keyword(s):

Sickle Cell Disease ◽

Sickle Cell ◽

Clinical Pathway ◽

Cell Disease

Download Full-text

PCV80 Characterization of the Clinical Pathway and Treatment Patterns for Post-Myocardial Infarction Patients: A Physician Survey

Value in Health ◽

10.1016/j.jval.2020.08.571 ◽

2020 ◽

Vol 23 ◽

pp. S501

Author(s):

N. Qureshi ◽

S. Antoniou ◽

J.H. Cornel ◽

F. Schiele ◽

P. Perrone-Filardi ◽

...

Keyword(s):

Myocardial Infarction ◽

Clinical Pathway ◽

Treatment Patterns ◽

Post Myocardial Infarction ◽

Physician Survey

Download Full-text

Definition of a novel vaccination pathway in PLWHA: experience of a Southern University Hospital

European Journal of Public Health ◽

10.1093/eurpub/ckaa166.837 ◽

2020 ◽

Vol 30 (Supplement_5) ◽

Author(s):

S D'Amato ◽

G F Pellicanò ◽

C Genovese ◽

F Mazzitelli ◽

G Nunnari ◽

...

Keyword(s):

Infectious Diseases ◽

Vaccination Coverage ◽

Clinical Pathway ◽

Drop Out ◽

University Hospital ◽

Treatment Center ◽

People Living With Hiv ◽

Vaccination Rates ◽

Operating Unit ◽

Hiv Aids

Abstract Background At the end of 2018 across the globe there are ∼37.9 million people with HIV/AIDS also thanks to the use of HAART which led to an increase in life expectancy. The Italy Immunization Plan 2017-19 recommend vaccines to these patients but a protocol still isn't present. Moreover, despite the availability of effective vaccines, coverage remained very low for many reasons including problems with privacy. The objectives of this study were a) the appliance of a shared clinical pathway between the “Immunization Center of Hospital Hygiene Operating Unit” and the “HIV/AIDS Disease Prevention, Diagnosis and Treatment Center of Infectious Diseases Operating Unit” b) the increase in vaccination coverage and the evaluation of side effects. Methods A prospective study was conducted from Oct 2019 to Feb 2020 at the G. Martino University Hospital of Messina. In particular, of the 138 patients followed by the Infectious Diseases OU, after evaluation of their immune status, 62% were enrolled in this study. Following the acquisition of informed consent, we collected socio-anagraphical data and we started the free administration of vaccines by providing an hoc calendar in the Immunization Center. Statistical analysis was performed with R software. Results The sample was represented by 86 patients (74% males and 26% females, 21% foreigners and 79% Italian, mean age=40±13.6 SD). We didn't observe drop out and no differences were observed for local/systemic AEs generally reported. We obtained an increase of vaccination coverage with a total of 74 doses administered for flu (+164%) and 240 for other vaccines (+172%). In particular, we immunized a total of 74% of patients for HPV (2% in 2018), 42% for HAV (28% in 2018), 37% for HBV (28% in 2018), 58% for pneumococcal (21% in 2018), 54% for meningococcal ACWY and B (0% in 2018). Conclusions The undertook clinical pathway showed the relevance of specific management of these patients and the need to increase the vaccination offer. Key messages The immunization in people living with HIV is priority to reduce the risk of infectious disease. It’s important to implement a shared clinical pathway to increase vaccination rates of these patients. The application of the protocol had an high impact in patients' adhesion to vaccination also thanks to the chance of accessing to the service in a comfortable setting and suitable to protect privacy.

Download Full-text